Steve Valiquette
Stock Analyst at Barclays
Total Price Targets
6
Stocks Covered
5
Sectors
Healthcare, Real Estate
Most Recent
Jun 11, 2024
Stocks Covered by Steve Valiquette
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| TDOC | Teladoc Health, Inc. | $20.00 | $6.48 | +208.6% | 2 | Jun 11, 2024 |
| GDRX | GoodRx Holdings, Inc. | $13.00 | $2.58 | +404.9% | 1 | Aug 9, 2022 |
| UNH | UnitedHealth Group Incorporated | $565.00 | $370.14 | +52.6% | 1 | Apr 3, 2022 |
| WELL | Welltower Inc. | $95.00 | $217.53 | -56.3% | 1 | Mar 14, 2022 |
| CAH | Cardinal Health, Inc. | $63.00 | $195.04 | -67.7% | 1 | Jan 17, 2022 |
Recent Activity
- Jun 11, 2024— Set$20.00price target onTDOC(Teladoc Health, Inc.)
- Aug 9, 2022— Set$13.00price target onGDRX(GoodRx Holdings, Inc.)
- Jul 31, 2022— Set$42.00price target onTDOC(Teladoc Health, Inc.)
- Apr 3, 2022— Set$565.00price target onUNH(UnitedHealth Group Incorporated)
- Mar 14, 2022— Set$95.00price target onWELL(Welltower Inc.)
- Jan 17, 2022— Set$63.00price target onCAH(Cardinal Health, Inc.)
Frequently Asked Questions
Who is Steve Valiquette?
Steve Valiquette is a stock analyst at Barclays covering 5 stocks primarily in Healthcare, Real Estate. They have issued 6 price targets since Jan 17, 2022.
What stocks does Steve Valiquette cover?
Steve Valiquette currently covers 5 stocks, including TDOC, GDRX, UNH, WELL, CAH.
What is Steve Valiquette's latest price target?
Steve Valiquette's most recent price target was $20.00 on TDOC (Teladoc Health, Inc.), set on Jun 11, 2024.
What is Steve Valiquette's highest price target?
Steve Valiquette's highest issued price target is $565.00 on UNH, set on Apr 3, 2022.
More Analysts at Barclays
Coverage based on publicly published price targets. Not investment advice.